During apoptosis nuclear morphology changes dramatically due to alterations of chromatin architecture and cleavage of structural nuclear proteins . To characterize early events in apoptotic nuclear dismantling we have performed a proteomic study of apoptotic nuclei. To this end we have combined a cell-free apoptosis system with a proteomic platform based on the differential isotopic labeling of primary amines with N-nicotinoyloxy-succinimide. We exploited the ability of this system to produce nuclei arrested at di fferent stages of apoptosis to analyze proteome alterations which occur prior to or at a low level of caspase activation. We show that the majority of proteins affected at the onset of apoptosis are involved in chromatin architecture and RNA metabolism. Among them is DEK, an architectural chromatin protein which is linked to autoimmune disorders . The proteomic analysis points to the occurrence of multiple PTMs in early apoptotic nuclei. This is confirmed by showing that the level of phosphorylation of DEK is decreased following apoptosis induction. These results suggest the unexpected existence of an early crosstalk between cytoplasm and nucleus during apoptosis. They further es tablish a previously unrecognized link between DEK and cell death, which will prove useful in the elucidation of the physiological function of this protein.
Introduction
The demolition of the nucleus during apoptosis proceeds in distinct steps and through different shapes beginning with a more or less pronounced peripheral chromatin margination, 2 often accompanied by disruption of the nucleolus, to a late morphology characterized by shrinkage, convolution of the nuclear envelope, and fragmentation into apoptotic bodies [1, 2) . These structural changes are mainly the consequence of the proteolysis of nuclear proteins like lamins and Tpr, and of chromatin cleavage into high-molecular weight and oligonucleosomal fragments [3-6). The major execution system involved in these processes is the caspase family of proteases [7) . These enzymes can directly cleave nuclear proteins and activate apopototic DNases like caspase-activated DNase (CAD)/DNA fragmentation factor (DFF40) . In addition, several caspase-independent factors were shown to contribute to apoptotic nuclear alterations, including AIF [8) , endonuclease G [9), DNaseIl [10) , phospholipase A2 [11) , and Acinus [12) .
Abnormalities in the packaging of nuclear constituents into apoptotic bodies and their subsequent clearance by phagocytosing cells may lead to the expos ure of novel antigens and the initiation of an autoimmune response. Indeed, circulating antinuclear autoantibodies are a hallmark of many systemic autoimmune disorders [13, 14) . Apoptosisinduced PTMs of nuclear proteins may increment the immunogenicity of self-antigens [15) . Therefore, the study of apoptosis-induced structural and functional alterations of nuclear proteins is of crucial importance to understand the mechanisms regulating apoptotic nuclear dismantling and its connection to autoimm unity.
The technique of choice to achieve a comprehensive characterization of changes in the protein complement of the nucleus during apoptosis is subcellula r proteomics [16) . This strategy usually consists of a combination of cell fractionation procedures and comparative proteomic analysis of the compartment of interest, in this case purified nuclei. The main advantage of this approach is the enrichment of lowabundance proteins which may remain undetected when total crude extract is employed as starting material, mainly due to the limited resolving capacity of2-DE [17) .
Subcellular proteomic studies of apoptosis are still sparse so far. Two groups have reported on the translocation of hnRNP proteins out of the nucleus during cell death [18, 19) and characterized apoptosis-induced alterations of the nuclear matrix [20) . They both employed the classical approach of comparative high-resolution 2-DE of nuclear fractions followed by the mass spectrometric analysis of interesting spots. The range of pI that was analyzed extended from approximately 5 to 9 in one case [18) , and from 4 to 7.5 in another case [20) . However, a large number of nuclear proteins, in particular those directly binding to DNA, are positively charged and migrate at pI values > 10. Such proteins are difficult to identify by conventional approaches due to the poor resolution and reproducibility of 2-Dgels in the basic region [21) .
In this work we have employed an alternative strategy to perform a proteomic study of apoptotic nuclei. We exploited a recently developed technique of stable isotopic labeling of protein mixtures, termed ICPL (isotope coded protein label), which was successfully employed for the analysis of basic proteins [22) . Similarly to the isotope coded affinity tag (ICAT) platform pioneered by Aebersold and coworkers [23) , the protein samples to be compared are chemically derivatized with two distinguishable isotopic forms (li ght, nondeuterated, do and heavy, deuterated, d 4 ) of the ICPL reagent, N-nicotinoyloxy-succinimide [22) . The differentially labeled samples are subsequently combined and separated by high-resolution 2-DE. Here, proteins labeled with isotopically different forms of the ICPL reagent coseparate and are recovered from the same spot. Changes in protein abundances are then accurately determined by comparing the ratio of the mass spectrometric signal intensities of the heavy and light forms of the labeled peptides. Differently from the ICAT reagent, which labels cysteines, the ICPL reagent quantitatively modifies primary amino groups. This reduces the pI of the labeled proteins and shifts the position of the corresponding spots in 2-DE to the acidic side. The magnitude of the shift is proportional to the number of basic amino groups present. Highly basic proteins, such as nuclear proteins, can thus be separated in the neutral to acidic region of the gels, where resolution is not a problem [22) .
Cell-free apoptosis systems have been instrumental to the identification of many factors involved in apoptotic nuclear execution [24) . Typically, these systems consist of nuclei purified from healthy cells or tissues and cytosolic extracts derived from cells stimulated to undergo apoptosis [25] [26] [27] . One advantage of this approach is that apoptotic alterations are induced in all nuclei independently of the variable responsiveness of individual cells to the apoptotic trigger. The stage of apoptosis reached in these nuclei depends on the time point at which the cells are harvested for extract isolation after apoptosis induction. The process of nuclear destruction can thus be temporally dissected. In particular, this method allows for the study of early apoptotic events which are difficult to observe in a cell population due to the asynchronous onset of the apoptotic process.
Goal of this study was the identification of early alterations of the nuclear proteome, which may occur prior, or at the beginning of the caspase cascade. To this end we have exploited cell-free apoptosis as a technique to generate early apoptotic nuclei and performed a comparative proteomic study using the ICPL platform.
Our results show that already prior to detectable alterations of chromatin structure and preceding the full activation of executioner caspases a number of nuclear proteins are altered in death receptor-induced cell death. The majority of the identified proteins participate in chromatin function and RNA metabolism. Among them is DEK, an architectural chromatin factor that has been implicated in the pathogenesis of cancer and autoimmune disorders [28, 29) . The involvement of DNA and RNA-binding factors in the early phase of a poptosis is a previously unrecognized aspect of the receptor mediated death pathway.
Cell culture, apoptosis induction, and measurement of caspase activity
Jurkat T-cells (Clone E6-1) were grown in RPMI 1640 medium containing 5% FCS at 37°C in a humidified atmosphere. For induction of apoptosis cells were incubated in serum-free medium at a density of 5 x 10 6 cells/mL with 2.5% C09s ligand (C09s-L}-containing culture supernatant from C09S-L-expressing N2A cells [30J. Apoptosis in the culture was monitored at regular intervals by staining aliquots of the cells with a combination of the fl uorescent chromatin dyes Hoechst 33342 (500 ng/mL) and Sytox (500 11M}. Cells impermea ble to Sytox and with condensed or fragmented nuclei were scored as apoptotic.
Caspase activity was determined essentially as described previously [4J. Briefly, cells were lysed in 25 mM HEPES pH 7.5, 5 mM MgCl z , 1 mM EGTA, 0.5% Triton X-1 00 and the cleavage of OEVO-afc (40 ~lM) was monitored fluorimetrically in reaction buffer (SO mM H EPES pH 7.5, 10 mM OTT, 1% sucrose, 0.1% CHAPS) over a period of 20m in at 37°C with Aex = 390 nm and Aem = 50S nm. The activity was calibrated using afc standard solu tions . Measurements were run in triplicate.
Isolation of cytosolic extracts
Cells were harvested by centrifugation at 4°C, washed twice carefully in ice-cold PBS and once in transport buffer (20 mM H EPES, pH 7.3, 110 mM potassium acetate,S mM sodium acetate, 2 mM magnesium acetate, 0.5 M EGTA, 250 mM sucrose) supplemented with protease inhibitors and 1 mM OTT. After addition of an amount of transport buffer corres ponding to the same volume of the packed' cell pellet containing 2.4mg/mL digitonin (equivalent to 60 Ilg digitonin/5 x 10 7 cells) the cells were lysed for 10 s under vigorous stirring, followed by incubation on ice for 3 min. Organelles and cell debris were removed by centrifugation at 18000 x g for 15 m in at 4°C. The supernatant was snap froze n and stored at -80°C.
Isolation of mouse liver nuclei
Isolation of nuclei was performed according to the protocol of Blobel and Potter [31J with modifications introduced by Cordes [32J. All separation steps were performed at 4°C. All buffers were supplemented with 1 mM OTT and 30 Ilg/mL trypsin-inhibitor immediately before usage. Liver tissue of2-30 g from C3HeB/FeJ mice were homogenized in 50-100 mL of ice-cold buffer A (15% sucrose, 1 mM Tris/HCI pH 7.2, 70 mM KCI , 2 mM MgCl z ). The homogenate was filtered through gaze and centrifuged for 10 min at 4°C and 1000 x g. The pellet was resuspended in buffer A and mixed with a 92% sucrose solution in 10 mM Tris/ HCI pH 7.2 and 2 mM MgCIz to yield a 70% sucrose suspension that was finally 3 transferred on top of 72% sucrose cushions. Nuclei were separated by centrifugation fo r 60 min at 4°C and 40000 x g. The pelleted nuclei were resuspended in an adequate volume of buffer A, dounced and centrifuged again for 10 min at 4°C and 1000 x g. Nuclei were stored at -80°C in buffer A supplemented with 20% glycerol.
Cell-free apoptosis reaction
Purified mouse liver nuclei (1 x lOs) were incubated with a volume of cytosolic extract corresponding to 4 mg of total protein in extract dilution buffer (10 mM HEPE S pH 7.0, 50 m M NaC!, 2 m M MgCl z , 5 mM EGTA) in a total volume of 600 ~lL. The reactions were supplemented with an ATP regenerating system (10 mM phosphocreatine, 2 mM ATP, 1 mM OTT, and 15-20 mU/mg creatine phosphokinase) and incubated at 37°C under moderate shaking (300 x rpm) for 10min. The nuclei were then recovered from the reaction mixture by centrifugation through a small sucrose step gradient consisting of 40 and 15% sucrose cushions (500 ~IL each) in 10 mM Tris/HCI pH 7.2 for 2 min at 4°C and 10000 x g.
Preparation of samples for immunoblot analysis
For the preparation of whole cell extracts, Jurkat cells were harvested by centrifugation, washed in ice-cold PBS, resuspended in 95°C lysis buffer (50 m M Tris /HCI pH 8.0, 0.5% SOS , 1 mM OTT) , and heated at 95°C for 10min. Cell debris was removed by centrifugation at 20000 x g for 10 min.
Extracts for the analysis of cytochrome c release from mitochondria were prepared by selective digitonin permeabilization of the plasma membrane as described by Single et al. [33J. Briefly, 4 x 10 6 cells were harvested and res uspended in 250 ~lL PBS. Plasma membrane lysis was performed by adding 25 0 ~IL of digitonin solution (130 ~lg/mL in sOOmM sucrose) to the cell suspension under vigorous stirring on a vortex for 10 s and further incubation at RT for 30 s. The cytosolic fraction was quickly isolated by centrifugation fo r 60 s at 14000 x g and 4°C. Proteins in the supernatant were precipitated with 5% TCA at -20°C overnight.
For the analysis of nuclear proteins, nuclei recovered from the cell-free reaction (see above) were lysed in 95°C lysis buffer (SO mM Tris/HCI pH 8.0. 0.5% SOS , 1 mM OTT).
Antibodies and immunoblot analysis
Whole cell extracts were employed for the detection of caspase-8 and caspase-3 processing, and Bid cleavage. Mitochondrial cytochrome c release was analyzed in digitonin lysates, and cleavage of PARP-1 and lamin B in nuclear extracts.
Proteins were separated by SOS-PAGE according to Laemmli [34J, transferred to NC membranes (Amersham Pharmacia Biotech, Uppsala, Sweden), blocked with 5% nonfat dri ed milk in TBST (SO mM Tris/HCI pH 8.0, 0.05% Tween 20, 150 mM NaCl) for 1 h at RT and incubated with primary antibodies specific for caspase-8 and caspase-3 (CelJ Signaling Technology, Danvers, MA, USA), cytochrome c (Becton Oiclcinson Biosciences, Franklin Lakes, NJ, USA) , Bid (Biosource International, CamarilJo, CA, USA), lamin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and PARP-1 (clone ClI-10, kind gift of A. Buerkle) diluted in TBST containing 5% nonfat dry milk for 1 h at RT. Filter washings were in TBST alone. Incubations with HRP-coupled secondary antibodies were in TBST-milk at room temperature for 1 h . The Super Signal Western blotting detection system (Pierce Biotechnology, Rockford, IL, USA) was used according to the manufacturer's instructions.
DNA fragmentation assay
Nuclei recovered from the cell-free apoptosis reaction (3-5 x 10 5 ) were dissolved in 200 ~IL DNA lysis buffer (100 mM Tris/HCI pH 8.5, 5 mM EDTA, 0.2% SOS, 200mM NaCl) and incubated for 4h at 37°C with 100 Ilg/mL proteinase K. After separation of insoluble material, the DNA was recovered from the supernatant by isopropanol precipitation, resuspended in TE buffer and treated with 1 mg/mL RNase for 30 min at 37°C. Oligonucleosomal DNA fragments were separated by conventional 1% ·agarose gel electrophoresis and visualized on a UV transilluminator after staining the gel with SybrGreen (Molecular Probes, Eu gene, OR, USA) according to the manufacturer's instructions.
ICPL reagent labeling and 2-DE
An equal number of nuclei recovered from control and apoptotic cell-free reactions were dissolved in 6 M guanidine/HCI pH 8.5 by sonication and vigoro us shaking. Insoluble material was removed by centrifugation. The supernatants were adjusted to the same protein concentration (5 mg/mL) and labeled with the do-(light, control) and d 4 -(heavy, apoptosis) substituted isoforms of N-nicotinoylsuccinimide, respectively, as described in Schmidt et al. [22] . Eq ual aliquots of the two samples were mixed and dialyzed (cutoff 8 kOa) in a buffer containing 8 M urea, 2 M thiourea, 4% CHAPS, and 40mM OTT. Carrier ampholytes pH 3-10 and Bromphenol blue were added to a final concentration of 2% (v/v) and 0.0075% (w/v) . Samples were appli ed to IPG strips with a linear separation range of pH 3-6 (Amersham Biosciences) . After overnight rehydration, IEF was carried out at 20°C and 80 kVh in the following steps: 1 h at 300 V folJowed by a 300 V increase every 15 min to 5000 V and 15 h at 5000 V. Strips were then soaked for 2 x 10 min in a buffer containing 50 mM Tris/ HCI, pH 8.8,6 M urea, 30% w/v glycerol and 4% w/v SOS and a trace of bromphenolblue. One percent w/v OTT was added to the first, 4% (w/v) iodoacetamide was added to the second equilibration step. Second dimension electrophoresis was performed with an Ettan Oalt II system (Arnersham Biosciences). IPG strips were placed on top of a 13% polyacrylamide gel and electrophoresis was carried out at 20°C for 1 h at a constant current of 5 mA per gel. The current was then increased to 10 mA until the color front reached the lower end of the gel. Gels were silver-stained and scanned with a color image scanner (Sha rp JX-330, Mahwah, NJ, USA). Protein spots were excised with an automatic cutter (BioRad, Munich, Germany) and enzymatically cleaved ingel with trypsin (0.05 mg) overnight at 30°C. Protein fragments were eluted with acidic and organic solvents and vacuum dried as previously described [22] .
MALDI-TOF/TOF analysis and data processing
Eluted peptides were redissolved in 3 ~I L 50% ACN and 0.2% TFA. 0.4 ~IL of this solution were mixed with the same volume of matrix solution (CHCA, 2.5 mg/mL) on the MALOI target. Mass spectra were acquired with a Proteomics Analyzer 4700 (MALOI-TOF/TOF) mass spectrometer (Applied Biosystems, Forster City, CA, USA). Mass analysis was performed in the positive reflector mode with a deflection cut-off range corresponding to a mass/charge ratio of 800. A total of 2500 shots were carried out for both the MALDI-TOF and the MALOI-TOF/TOF experiments. To identify modified proteins, spectra were searched against the Swiss-Prot database using an in-house version of MAS -COT [35] . Only those proteins were taken into further consideration that were identified on the basis of at least two di fferent peptides within one single MS spectrum. Protein quantification was performed using the Peakpicker software (Applied Biosystems) , which automatically calculates the relative abundance of light (do, control) and heavy (d 4 , apoptotic) ICPL-labeled pep tides as a ratio of light versus heavy. The d o :d 4 ratios determined within one MS spectrum were averaged and the SO was calculated (see Supplementary Table 1 ). The d o :d 4 ratio of a protein was considered significantly altered if the determined averaged value was greater than twice the SO.
In vitro phosphorylation
S-20 extracts were prepared from healthy Jurkat cells or Jurkat cells treated with C095-L for the indicated time periods. Cells were resuspended in hypotonic buffer (10 mM HEPES, pH 7.5, 5 mM KCI, 1.5 mM MgCI 2 , 0.1 mM OTT) supplemented with 250 mM sucrose. After centrifugation (164 x g, 5 min, 4°q the cell pelJet was redissolved in hypotonic buffer without sucrose, kept on ice for 30 min and Oounce homogenized to prepare the soluble cytoplasmic and nucleoplasmic proteins. The in vitro phosphorylation wa s carried out exactly as described in Kappes et al. [36] .
In vivo labeling with 32Pi
Labeling of Jurkat cells with 32Pi was performed by washing celJs (1 x 10 8 ) three times with phosphate-and serum-free RPMI medium and then cultivating them in 2 mL of phosphate-and serum-free medium supplemented with 200 ~lCi of 32Pi (carrier free; [CN) for the indicated time points. For induction of apoptosis cells were treated with 2.5% CD95-Lcontaining culture supernatant from CD9S-L-expressing N2A cells [30] exactly as described above. Cells were harvested by centrifugation (500 x g, 5 min) and washed twice with ice-cold PBS, once with hypotonic buffer (20mM NaCI, 20mM HEPES, pH 7.4, 5 mM MgCl z ) followed by incubation in 2 mL hypotonic buffer supplemented with 0.5% NP-40 and protease (Complete, Roche) and phosphatase inhibitors (NaF , Na-vanadate) for 15 min on ice. After adjusting the cell suspension to 450 mM NaCl and incubation for further 15 min on ice, insoluble material was pelleted (1000 x g, 10 min) and the supernatant (whole cell lysate) was used for immunoprecipitation with DEK specific antibodies. Five micrograms of affinity purified polyclonal DEK antibody [36] were used for the equivalent of 1 x 10 6 cells. After 1 h incubation on ice, 30 ~lL of a 50% protein A-Sepharose solution (Amersham Pharmacia) was added and the mixture was roIled at 4°C for another hour. The immunocomplexes were washed three times with 1 mL of extraction buffer (450 mM NaCl, 20 mM HEPES, pH 7.4, 0.5 mM MgCl z ) followed by dissociation from the beads with 2% SDS and 5% p-mercaptoethanol at 37°C for 1 h. The samples were separated by SDS-PAGE, blotted to NC and analyzed by autoradiography and immunoblotting.
Results and discussion

A novel combination of cell-free apoptosis and proteomics
The strategy employed here for the proteomic analysis of early apoptosis-induced nuclear alterations is outlined in Fig. 1 . Apoptosis was induced in purified mouse liver nuclei by incubation with cytosolic extracts derived from CD95-L treated Jurkat cells . Control reactions were performed with extracts from untreated cells. Subsequently, the nuclei were recovered from the cell-free reactions and subjected to the ICPL proteomic platform [22] . The CD95-L triggered apoptotic pathway is very well characterized [37] and leukemia cells treated with CD95-L have been used as a source of cytosolic extracts for cell-free apoptosis reactions in the past (s ee e.g. [26, 27, 38] ) . To choose the time points of cell harvesting to isolate the extracts, we first analyzed known signal transduction steps triggered by CD95-L (Fig. 2) . The results showed that initiator caspase-8, the most upstream caspase in this pathway, was already active at 40 min after treatment, as indicated by the appearance of the p18 active subunit in the corresponding immunoblot ( Fig. 2A) . Within 5 min, caspase-8 processing was followed by cleavage of Bid , release of cytochrome c, and partial processing of caspase-3. Caspase 3/7-like activity (D EVDase) became detecta ble at 60 min after initial stimulation, followed by the condensation of chromatin at 90 min Protein identification and quantitation Figure 1 . Strategy of the ce ll-free apoptosis/proteomic approach.
Nuclear apoptos is was induced in vitro by comb inin g nuclei isolated from mouse li vers with cytosolic extracts derived from Jurkat cells stimulated with CD95-L. Control nuclei were incubated with extracts from untreated ce ll s.· The nuclei were recovered from the cell -free reactions by sedimentation through a small sucrose gradient and dissolved in a guanidine-containing buffer. The soluble material was subjected to differential labeling with th e ICPL reage nt: proteins of control nuclei were modified with the light, nondeuterated (dO) form of the reagent, proteins of apoptotic nuclei with the heavy, deuterated (d , ) form. Equal amounts of each reaction were combined and the mixed sample separated by 2-DE. After spot excision, proteins were digested ingel with trypsin and the resu lting material subjected to mas s spectrometric ana lysis (MALDI-TOFITOF). Protein identification was performed by screening against the Swiss-Prot database.
( Fig.2B) . zVA D-fmk efficiently blocked the appearance of apoptotic signaling intermediates and cell death, confirming the caspase-dependency of this pathway. We then verified the ability of extracts isolated at different time points from CD95-L stimulatiori to induce distinct stages of apoptosis in isolated liver nuclei by immunoblot analysis of two classical caspase targets, PARP-1 and Jamin B Fo r eac h data point > 100 ce ll s were sco red in at least three different microscopic fields. Caspase-3/7 -li ke activity was determined f lu orimetrica lly by DEVD-afc cleavage. The data are representative of at least three indepe ndent expe riments.
( Fig. 3A) . by DNA fragmentation analysis (Fig. 3B) . and by microscopic inspection of chromatin structure (Fig. 3C) . The characteristic apoptotic signature fragments of PARP-! (89 kDa) and lamin B (46 kDa) were barely visible after incubation of the nuclei with extracts obtained at 60 min from initial stimulation (Fig. 3A) , when active caspases were present at a low level and only a small fraction (20%) of the population displayed condensed nuclei ( Fig. 2A and B) . Neither oligonucleosomal fragmentation nor gross alteration of chromatin structure were detected in these nuclei ( Fig. 3B and C) . By contrast. 120 min-extracts induced substantial PARP-1 and lamin B cleavage as well as oligonucleosomal laddering ( Fig. 3A and B these samples revealed loss of chromatin and nucleolar structures, as well as the induction of peripheral chromatin condensation (Fig. 3C ). These data demonstrate on the one hand, that the in vitl'O system employed here correctly recapitulates the major features of nuclear apoptosis. On the other hand, they show that the system can be exploited to obtain nuclei arrested at distinct apoptotic stages. Importantly, we did not observe an increase in caspase activity in the isolated extracts during cell-free incubations (data not shown) as could potentially occurr by spontaneous formation of the apoptosome, a caspase-activating multimeric complex [39] . This is most likely due to the high osmolarity of the buffers used for cell extraction and for cell-free incubations (110 mM K+ and 70--80 mM K+, respectively) which was shown to efficiently inhibit apoptosome formation [40, 41] .
Since we were interested in early apoptotic alterations of the nuclear proteome we wished to isolate cytosolic extracts from cells committed to , but not yet fully engaged in apoptotic execution. For the subsequent experiments we therefore prepared extracts at 30 and 60 min after CD9S-L treatment. The first time point (30 min) was precedent to caspase activation and apopto tic cell death, whereas at 60 min a minor fraction of the population displayed an apoptotic morphology. as shown above (Fig. 2B ).
Compared to subcellular proteomic approaches based on the biochemical fractionation of cells undergoing apoptosis the combination of cell-free apoptosis and proteomics described here has the following distinguishing features: (i) Subcellular fractionation bears a notoriously high risk of cross-contamination. In apoptotic cells this is aggrava ted by the generation of reactive oxygen species (ROS) (42) that compromise the stability of intracellular membranes. Therefore, frac tionation protocols established for healthy cells may not be suited for cells undergoing apoptosis. Here, isolating nuclei from a healthy tissue prior to apoptosis induction minimizes the risk of contamination of the nuclei with non-nuclear proteins. (ii) The components of the cell-free reaction, nuclei and cytosol, can be easily isolated and stored in large quantities. Therefo re, reactions can be repeated from identical starting material keeping variations in sample preparation to a minimum. (iii) Due to the synchronicity of nuclea r apoptosis triggered in vitro, homogenous sample material corresponding to different stages of the apoptotic process can be gained using extracts isolated at different time points from stimulation.
Finally, the reconstituted cell-free apoptosis reaction is unlikely to sustain de novo gene expression in the absence of RNAse inhibitors and without the addition of exogenous precursors. Since caspase-mediate protein cleavage is kept at a low level by the choice of cytosolic extracts (see above), alterations of the nuclear proteome in these reactions will occur predominantly by post-translational events, like protein modifications and migration in and out of the nucleus. These events play an important role in the early cytosol to nucleus signaling phase of apo ptosis that we wished to characterize [43] [44] [45] . The ICPL technology in turn, has been shown to be particularly suited for the detection of different protein isoforms and protein modifications since it provides good sequence coverage and introduces the iso topic label used for quantification at the protein instead of the peptide level, as e.g., in GIST [22, 46) . Other techniques for quantitative protein profiling, like SILACJ2-DE, have also been employed in similar studies with good results (47). Here, one major advantage was the shift in pI introduced by the isotopic label, which allowed to analyze basic nuclear proteins in the neutral region of the 2-DE (see Section 1). The pI of the proteins is preserved also in DIG E, another common quantitative proteomic platfo rm, which in addition may encounter problems in complex protein mixtures when two or more proteins comigrate [48) . Recently, COFRADIC, a peptide-based proteomic approach, has been successfully applied to the characterization of apoptosis-induced protein degradation (49) . While this method proved very powerful for the detection of protein fragmentation in late apopto tic cells, its exclusive detection of N-terminal peptides is not suited for the study of early stages of apoptosis, where the majority of changes are due to PTMs not necessaril y located at the N-terminus.
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In sum, we present here a novel combination of cell-free apoptosis and the ICPL proteomic platform direct:ed at the specific detection of early events of nuclear apoptosis, as induced by dea th-receptor stimulation.
Proteome analysis of early apoptotic nuclei
In an initial experiment we first verified whether we would be able to identify ICPL-modified basic nuclear pr oteins in the neutral region of a 2-Dgel taking histone prote ins as an example. Indeed, histone 1.0, which has a calculated pI value of10.9 migrated after ICPL-modification below pI 6 (Fig. 4A  upper and lower panel) .
Since the control and apoptotic sample were mixed prior to 2-DE, each ICPL-labeled peptide appeared in the mass spectrum as a pair of closely spaced peaks corresponding to the do (control, ligh t)-and d 4 (apoptotic, heavy) isoform of the reagent. The mass difference between these peaks amounted to 4 Da or a multiple of 4 Da depending on the number of ICPL-modified residues presen t in the peptide sequence. This is demonstrated for the RNA-binding protein hnRNP C in Fig. 4B . Changes in protein abundance due to the exposure to apoptotic extracts are expressed as the ratio of the peak intensities in each doublet. In this case, a 60% decrease in protein level (ratio d o :d 4 = 1:0.44) was detected in nuclei treated with a 60 min-extract (Fig. 4B , lower panel) , while no significant change was visible when the 30 minextract was used (ratio d o :d 4 = 1:1.01, Fig. 4B , upper panel) . Peptides showing a change in peak intensities were subjected to MALDI-TOF/TO F for protein identification (Fig.4C) .
The procedure of cell-free apoptosis/proteomic analysis described in Fig. 1 was performed three times using different preparations of extracts and nuclei. In total, 40 proteins were found to be differentially regulated (Supplementary Table 1 ). Two ofthem were detected only in nuclei exposed to 30 m in-extracts, 25 only in nuclei treated with 60 minextracts, and 13 in both type of samples . Two major classes of pro teins emerged from this analysis: chromatin-binding and RNA-processing factors. The first group included several histones, the high-mobility group proteins HMGBI and B2, the hepatocellular carcinoma protein Hcc-l, heterochromatin-binding protein 1 y (HPI y), and the architectural chromatin factor DEK. RNA-binding proteins comprised hnRNPs and splicing fac to rs like U2 snRNPA', snRNP core smx5 , ASF/SF2, and a protein similar to the splicing facto r arginine/serine-rich (3 5 kDa) . Five candidates, i.e., DEI<, snRNP A', snRNP core smx5, ribosomal protein S7, and DEAD-box protein 48 (Ddx 48) have not been implicated in cell death so far and thus represent potential novel mediators of nuclear apoptosis.
With few exceptions all proteins were found to be of murine origin (see Supplementary Table 1) indicating that nuclei and cytosol could be efficiently separated after the cellfree reaction and that carry-over of cytosolic components was minimal. The only human prote ins detected were: hnRNP H' and I<, Ran, peroxiredoxin I, and ubiquitin. Different mechanisms and observations may account for this: hnRNP H', hnRNP K, and Ran bear nuclear localization sequences which may support their nuclear entry (see e.g. [50, 51] ). Per· oxiredoxin [fthioredoxin peroxidase-2 is typically located in the cytosol, but has been recently detected also in the nucleus oflung cancer cells [52] . Human ubiquitin and the mouse Ubc protein, the latter identical to polyubiquitin, were recovered from protein spots migrating in the 2-D E between M, 15 and 20kDa. These most likely represent proteins which are modified with human ubiquitin during the cell-free incubation.
The majority of the identified proteins migrated in the 2·DE as closely spaced spots (Fig. 5) . Their position was mostly shifted only in the horizontal dimension reflecting the presence of different species of the same protein differing in pi but not in molecular weight. Some of the neighboring spots also showed a reciprocal change in the abundance of the corresponding peptide, possibly indicating conversion of one protein species into another (see scatter plots for DEI<, Hcc-1, and histone Hl.O in Fig. 5). [n general th e ratio of isotopically li ght and heavy labeled peptides was moderate compared to those achieved by changes in gene expression [53J . These values, which indicate the relative factor of decrease or increase of the corresponding proteins in the apoptotic sample as compared to control, ranged from 0.28 to 1.96 (see Supplementary Table 1) . Collectively these observations corroborate our assumption that nuclear protein alterations in the cell-free apoptosis reaction are mainly arising from post-translational processes rather than from de novo gene expression.
Chromatin-binding proteins in nuclear apoptosis
Histone modifications are known to modulate chromatin architecture and function, and have been associated with apoptosis both by proteomic and nonproteomic studies (see Supplementary Table 1 ). Modifications that have been observed in different model systems of cellular damage include dephosphorylation of HI family histones [54J, de-ubiquitination ofH2A (55] , poly(ADP-ribosyl)ation of HI (56] , biotinylation of HI, H2A, H2B, H3, and H4 (57] , hypoacetylation of H4 (58] , and phosphorylation bf H2B (59] . In the present study, we have identified Hl.4 as a further potential target for apoptosis-specific modification. In general these modifications are believed to increase the accessibility of chromatin for apoptotic endonucleases favoring chromatin condensation, although the exact mechanisms linking histone modification to these processes are not yet understood (60] . Histones may eventually separate from chromatin and be released from the nucleus and/or be exposed at the cell surface as potent autoantigens (61, 62] . In irradiated cells nuclear release ofH1.2 has been shown to function as apoptotic signal directed at the mitochondria (63] . High-mobility group proteins are DNA-binding factors affecting chromatin architecture and act in concert with histones in regulating chromatin function (64] . Similarly to histones, their PTMs, in particular methylation, dephosphorylation, and poly(ADP-ribosyl)ation have been associated with · apoptosis (65) (66) (67) . HMG B2 has further been shown to activate the apoptotic endonuclease DFF40 in vitro (68] . To our knowledge, the present study provides the first proteomic data supporting an involvement of HMGB2 in apoptosis. The distribution pattern of HMGB2-specific signals on the 2-DE shows three closely spaced spots, suggestive of PTMs. Whether these modifications are involved in the ability of HMGB2 to activate DFF40 remains an open question.
Hcc-l is a component of the nuclear matrix that is upregulated in a number of tumors and possesses a conserved Nterminal DNA-binding SAP (SAF AjB, Acinus, Pias) domain (69, 70] . When expressed in mammalian cells, Hcc-1 exerts an antiproliferative effect that has been attributed to cell cycle arrest at the G2/M boundary and more recently to induction of apoptosis (70] . Interestingly, Hcc-1 has been reported to interact with two DEAD-box proteins, Batl and Ddx39 (70] . These are members of a broad family of RNA-binding ATPases with helicase activity that are involved in virtually all cellular processes requiring manipulation of RNA structure (71] . One member of this family, Ddx48, that has not been involved in apoptosis so far, has been identified also in our proteomic screen (Supplementary Table 1) .
A further candidate mediator of nuclear apoptosis that emerged from this study is HPI y. HP1 is a chromatinbinding protein that occurs in three isoforms (1., ~, and y, and plays a major role in the maintenance and inheritance of pericentric heterochromatin (reviewed in (72] ). All three isoforms have been shown to interact with histones, in particular with histone H3 (73] . This interaction is strongly affected by post-translational histone modification and was proposed to mediate binding of HP1 to lamin B receptor (LBR), a component of the nuclear envelope, providing a mechanism for the tethering of HP1-enriched heterochromatic domains to the nuclear envelope (74] .
Finally, we identified DEI<, a chromatin bound nuclear phosphoprotein that does not belong to any known protein family and has not been associated with apoptosis so far. The only recognizable functional domain is a SAP-box _ Proteins containing this DNA-binding motif participate in chromatin organization, mRNA processing and transcription, and DEI< was implicated in all these processes (reviewed in (28] ) . Despite these findings the function of DEI< remains unclear.
In summary, using an in vitro assay consisting of nuclei from healthy tissue and early-phase apoptotic extract s we have identified histones, HMGs and a few other architectural chromatin proteins, including DEI<, as potentially involved in nuclear apoptosis. These results point to the fact that signals affecting the topological organization of chromatin are directed to the nucleus already at an early stage of death-receptor triggered apoptosis, preceding the substantial activation of executor caspases and of DNA cleaving enzymes. This may represent a general feature of the commitment phase of apoptotic cell death. In line with these conclusions, Kroemer and coworkers have shown that a short pulse of staurosporine, an efficient inducer of apoptosis, induces in moderate alterations of chromatin morphology that do not necessarily result in cell death. This preapoptotic status was termed PACC, for preapoptotic chromatin condensation. PACC occurred independently of executor caspases and was not associated with oligonucleosomal DNA fragmentation (75] .
RNA-processing factors involved in nuclear apoptosis
Rearrangements of ribonucleoprotein-containing compartments leading to the formation of aggregates termed HERDS (heterogenous ectopic RNP-derived structures) have been detected during apoptosis by electron microscopy studies and were shown to accompany the typical apoptotic changes of chromatin structure (76) (77) (78) . Among the RNPs identified in HERDS are pre-mRNA-binding RNPs, hnRNPs,.and small nuclear RNPs, snRNPs, as well as other, non-snRNP splicing factors (77] . In addition to these morphological data, alterations of hnRNPs have been reported also by proteome studies in different models of cell death (see Supplementary Table 1) . HnRNPA2/Bl, a shuttling hnRNP, was found to accumulate in the cytoplasm ofCD95-L treated Jurkat cells (18], corroborating our own results . which show a consistent reduction of the hnRN PA2/B 1 level in nuclei incubated with apoptotic cytosol (Fig. 5) . This effect is among the few ones that we repeatedly observed in nuclei incubated with 30 min-extracts, i.e., in absence of active caspases, suggesting that alterations of hnRNPA2/Bl trafficking is among the very early nuclear events in CD95-Linduced apoptosis. We also detected a decrease of nuclear levels of hnRNP Cl/C2, a non shuttling hnRNP (79] . This hnRNP has been identified early on as a caspase substrate (80] . Proteolytic cleavage may partly account for the loss of hnRNP Cl/C2 from liver nuclei in the cell-free apoptosis reaction, but is not likely to playa major role, given the low level of active caspases in this system . More importantly, a caspase-independent mechanism of nuclear efflux ofhnRNP Cl/C2 has been recently described which does not involve proteolytic cleavage but the activation of a novel nuclear export signal located at the C-terminus of the protein by Rhoassociated kinase (81) .
Our study further revealed a reduction in the level of hnRNP H', hnRNP K, and hnRNP l. Little is known about the physiological significance of the involvement ofhnRNPs in apoptosis. hnRNP F and H have been shown to modulate the alternative splicing of Bcl-x pre-mRNA (82) and several hnRNPs have been identified in proteomic studies of apoptotic cells (see Supplementary Table 1 ) . This supports the assumption that alterations of hnRNP nucleo-cytoplasmic distribution and/or their PTMs may indeed have a functional significance in apoptosis.
Among the RNPs identified in this study are also splicing factors like the snRNP core protein Smx5, the U2 snRNP A'and ASF/SF2. While the molecular alterations occurring in this system remain to be determined, it is known from literature that modification of splicing factors by phosphorylation regulate protein-protein and protein-RNA interactions within the spliceosome. This may influence the progression of the splicing reaction and the choice of the splice-site in alternative splicing (reviewed in (83)). The induction of changes in the levels of specific splicing factors during exposure of nuclei to apopto'tic extracts may reflect an early reprogramming of splicing reactions as part of the commitment phase of apoptosis. In fact, many members of the apoptosis pathway were shown to be regulated by alternative splicing. These include the genes encoding Bcl-2 family members, several caspases, Apaf-1, the endonuclease DFF40/CAD, and CD95 (reviewed in (84) ).
Finally, our data point to an early involvement of the nucleolus in the CD95-dependent signal pathway. Two components of the 40 S ribosomal subunit were found to be altered in preapoptotic nuclei, S3A and S7. Also nucleophosmin, an abundant nucleolar phosphoprotein involved in ribosomal biogenesis was identified as a target of CD95-induced apoptosis. Several lines of evidence support a role of nucleophosmin as an antiapoptotic survival protein [85, 86) . More recently, nucleophosmin has been shown · to media te the antiapoptotic effects of NGF by binding and inhibiting the apoptotic DNAse DFF40/CAD in the presence of phosphatidylinositol 3,4,5-triphosphate (87). This function of nucleophosmin was proposed to be regulated by PTM, in particular by phosphorylation. The identification of nucleophosmin in our study suggests that the regulation of the nucleophosmin-CAD interaction by phosphorylation may represent also a novel regulatory component of death receptor-mediated apoptosis.
DEK is hypophosphorylated in apoptotic nuclei
One of the proteins identified in this study for which a link to apoptosis had nofbeen established so far is the chromatin architectural factor DEK. The DEK protein was initially identified as an oncogenic fusion with the nucleoporin CAN/ Nup214 in patients suffering from acute myeloid leukemia 11 (88) . An increased level of DEK mRNA in many cancerous cells has been reported suggesting that DEK may playa role in cellular transformation and senescence [89] [90] [91] [92] [93] [94] [95] . In addition, DEK has been shown to be a major antigen in s~veral autoimmune disorders (96) . However, the biological function of DEK and the molecular mechanisms by which it contributes to disease pathogenesis have not been clarified yet.
DEK is an abundant nuclear phosphoprotein (97) that is tightly associated with chromatin throughout the cell cycle [98) . In vitro, DEK was shown to modify chromatin topology by introducing constrained positive supercoils in closed circular DNA templates, an activity which requires topoisomerase I [99, 100) . The structural features of DEK have been reviewed recently and a model for the interaction of DEK with DNA has been proposed (28) . This model takes into account the observation that DEK's binding to DNA as well as its ability to form multimers are modulated by phosphorylation, mainly by the protein kinase CK2. Increasing the level of phosphorylation reduces the affinity ofDEK for DNA and augments its tendency to form aggregates [36, 101) .
In the 2-DE of the ICPL-Iabeled nuclear samples DEK was identified in two protein spots migrating at slightly different pI-but identical Mr-values, which was indicative of the occurrence of two differentially modified species of the protein. The determination of the ratio of light (do, control) to heavy (d 4 , apoptotic) isomer in both spots showed that in the apoptotic sample the more basic DEK-variant (spot a) was increased, while the more acidic (spot b) was d ecreased (Fig. 6A) . Considering that DEK is a known target for phosphorylation in vivo and in vitro, these data potentially indicated a change in the phosphorylation status of DEK in liver nuclei during the cell-free ~poptosis reaction. To confirm this we compared the ability of extracts gained from untreated and apoptotic Jurkat cells to phosphorylate recombinant Hista gged DEK under conditions identical to those employed for the cell-free apoptosis reaction. As shown in Fig. 6B extracts from healthy Jurkat cells induced a robust phosphorylation of D EK in vitro, in accordance to previous results with HeLa cell extracts [36) . A progressive decrease in the level of DEK phosphorylation was observed with extracts derived from Jurkat cells treated for different times with CD95-L, in line with our results from the proteome analysis of liver nuclei. Since this experiment was performed in the presence of phosphatase inhibitors, the decrease in phosphorylation is most likely due to a reduced kinase activity in the corresponding extracts and not to the induction of a D EK-specific phosphatase in the course of apoptosis. Finally, we were interested to determine whether a change in the level ofDEK phosphorylation would also occur in intact cells undergoing apoptosis. For this purpose Jurkat cells were labeled with 12p_ orthophosphate and incubated for different times in the presence or absence of CD95-L. Cleavage of PARP-1 occurred specifically and in a time-dependent manner in the CD95-L treated cultures as shown by immunoblot analysis (Fig. 6C) . No degradation of DEK could be detected in these cultures (Fig. 6C) . Autoradiography of immunoprecipitated . ORC-2, a component of the origin recognition complex, was unaffected in this experiment and served as a loading control (Fig. GC) . At present, the significance of DEK hypophosphorylation in apoptosis is unclear. A lower level ofDEK phosphorylation however, is expected to enhance its DNA binding activity. This in turn may contribute to keep DEK fixed to chromatin during the process of nuclear destruction and apoptotic body formation avoiding a potentially harmful release of the protein to the cytoplasm and th e extracellular space. Failure of the nuclear retention ofDEK may be relevant for its role as autoantigen. A similar scenario has been shown to apply for HMGBl, which can act as a potent proinflammatory stimulus when released by necrotic cells. In apopto tic cells, HMGB1 is irreversibly locl<ed to chromatin as a consequence of histone hypoacetylation [58] . As a further possibility, hypophosphorylated DEK may facilitate chromatin compaction by bridging between distant binding sites on the same or on different DNA strands via its two DNA-binding domains, as proposed by the model of Waldmann et al. [28] . Third, DEK hypophosphorylation in apoptosis may impinge on its postulated functions in splicing and transcription. In fact, dephosphorylation ofDEK has been shown to relieve transcriptional repression of the human immunodeficiency Virus type 2 (H IV-2) promoter [102] in mitogenically stimulated leukemia cells .
In summary we have shown that the DEI< protein is hypophosphorylated in apoptosis induced in vitro and in vivo. This validates our results from the proteomic analysis of nuclear apoptosis and highlights the potential of this approach for the investigation of apoptosis-induced PTMs. Furthermore, our results establish a previously unrecognized link between DEK and cell death, which will prove useful in the search for the physiological function of this protein.
Concluding remarks
Cell death by apoptosis is characterized by dramatic alterations of nuclear morphology and chromatin architecture. These are brought about mainly by the action of the caspase family of proteases, by apoptosis-specific endonucleases, and chromatin condensation factors. We have performed a proteomic screen of apoptotic nuclei using a combination of cell-free apoptosis and ICPL. Interestingly, part of the proteins identified in this study have emerged also from previous proteomic studies of apoptotic cells using different apoptotic stimuli, fractionation techniques, and proteomic platforms (for a complete reference list, see Supplementary  Table 1 ). While, on the one hand, this corroborates the significance of our data, on the other hand it shows that different strategies of proteomic analysis, each bearing different merits and disadvantages, may complement each other and collectively contribute to characterize apoptosis-induced alterations of the cellular proteome (see e.g. [48] ) . Since ICPL is a rather new platform, only very few reports using this technique are available at present. More studies are to be awaited in the future and will allow for accurate crosscomparison of this method with other quantitative protein profiling tools.
The study described h ere was aimed specifically at displaying changes of the protein complement of the nucleus triggered at an early phase of cell death. The identification of chromatin architectural proteins and ' RNA-processing factors in our screen suggests that initial steps of apoptotic signaling may occur in the nucleus prior to the full activation of the cytoplasmic caspase cascade. These steps may involve PTMs of nuclear proteins, as exemplified for the protein DEK. Assessing the role of the identified candidates and particularly of the hypophosphorylation of DEK, in the process of apoptotic cell death is a challenging endeavor for the future.
We 
